1. Home
  2. IMNN vs WCT Comparison

IMNN vs WCT Comparison

Compare IMNN & WCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNN
  • WCT
  • Stock Information
  • Founded
  • IMNN 1982
  • WCT 2012
  • Country
  • IMNN United States
  • WCT Hong Kong
  • Employees
  • IMNN N/A
  • WCT N/A
  • Industry
  • IMNN Biotechnology: Pharmaceutical Preparations
  • WCT
  • Sector
  • IMNN Health Care
  • WCT
  • Exchange
  • IMNN Nasdaq
  • WCT NYSE
  • Market Cap
  • IMNN 12.1M
  • WCT 12.1M
  • IPO Year
  • IMNN 1985
  • WCT 2024
  • Fundamental
  • Price
  • IMNN $7.61
  • WCT $0.21
  • Analyst Decision
  • IMNN Buy
  • WCT
  • Analyst Count
  • IMNN 2
  • WCT 0
  • Target Price
  • IMNN $210.00
  • WCT N/A
  • AVG Volume (30 Days)
  • IMNN 405.2K
  • WCT 2.9M
  • Earning Date
  • IMNN 08-05-2025
  • WCT 05-16-2025
  • Dividend Yield
  • IMNN N/A
  • WCT N/A
  • EPS Growth
  • IMNN N/A
  • WCT N/A
  • EPS
  • IMNN N/A
  • WCT N/A
  • Revenue
  • IMNN N/A
  • WCT $2,309,218.00
  • Revenue This Year
  • IMNN N/A
  • WCT N/A
  • Revenue Next Year
  • IMNN N/A
  • WCT N/A
  • P/E Ratio
  • IMNN N/A
  • WCT N/A
  • Revenue Growth
  • IMNN N/A
  • WCT N/A
  • 52 Week Low
  • IMNN $5.55
  • WCT $0.12
  • 52 Week High
  • IMNN $54.75
  • WCT $9.36
  • Technical
  • Relative Strength Index (RSI)
  • IMNN 38.74
  • WCT N/A
  • Support Level
  • IMNN $6.51
  • WCT N/A
  • Resistance Level
  • IMNN $8.10
  • WCT N/A
  • Average True Range (ATR)
  • IMNN 1.32
  • WCT 0.00
  • MACD
  • IMNN 0.20
  • WCT 0.00
  • Stochastic Oscillator
  • IMNN 20.04
  • WCT 0.00

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).

About WCT WELLCHANGE HOLDINGS COMPANY LIMITED

Wellchange Holdings Co Ltd is an enterprise software solution services provider. It provides software solutions, cloud-based software-as-a-service (SaaS) platforms, and white-label software design and development services.

Share on Social Networks: